Gainers

• Rexahn Pharmaceuticals, Inc. (NASDAQ:REXN) stock increased by 44.72% to $4.11 during Thursday's pre-market session.

• Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) stock rose 27.87% to $3.90. The most recent rating by Citigroup, on Jun 11, is at Neutral, with a price target of $4.

• Tonix Pharmaceuticals, Inc. (NASDAQ:TNXP) shares rose 27.59% to $0.80.

• Evolus, Inc. (NASDAQ:EOLS) shares increased by 24.06% to $6.24. The most recent rating by Mizuho, on May 12, is at Buy, with a price target of $8.

• Biocept, Inc. (NASDAQ:BIOC) stock rose 11.56% to $0.72.

• Forward Pharma, Inc. (NASDAQ:FWP) stock increased by 10.51% to $8.20.

• Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) stock increased by 10.05% to $0.65. The most recent rating by H.C. Wainwright, on May 8, is at Neutral, with a price target of $0.

• Royalty Pharma, Inc. (NASDAQ:RPRX) shares rose 9.65% to $53.30.

• Regulus Therapeutics, Inc. (NASDAQ:RGLS) shares moved upwards by 8.76% to $0.96. The most recent rating by HC Wainwright & Co., on May 4, is at Buy, with a price target of $2.

• Celsion, Inc. (NASDAQ:CLSN) shares increased by 8% to $4.59.

Losers

• Brickell Biotech, Inc. (NASDAQ:BBI) stock decreased by 17.05% to $1.07 during Thursday's pre-market session.

• Zealand Pharma, Inc. (NASDAQ:ZEAL) stock declined 11.21% to $36.21. The most recent rating by Morgan Stanley, on Apr 15, is at Overweight, with a price target of $37.

• Catalyst Biosciences, Inc. (NASDAQ:CBIO) shares declined 9.90% to $6.55.

• Millendo Therapeutics, Inc. (NASDAQ:MLND) shares declined 8.84% to $2.99. The most recent rating by Citigroup, on May 29, is at Buy, with a price target of $6.

• Miragen Therapeutics, Inc. (NASDAQ:MGEN) stock decreased by 7.94% to $1.16.

• IVERIC bio, Inc. (NASDAQ:ISEE) shares decreased by 7.66% to $4.10.

• Precipio, Inc. (NASDAQ:PRPO) shares fell 6.19% to $1.06.

• Brainsway, Inc. (NASDAQ:BWAY) stock fell 4.95% to $6.72. The most recent rating by Raymond James, on Mar 24, is at Outperform, with a price target of $9.

• Ra Medical Systems, Inc. (NYSE:RMED) shares fell 4.85% to $0.59. The most recent rating by Piper Sandler, on May 14, is at Neutral, with a price target of $1.

• Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) stock fell 4.62% to $0.31.